A Washington state high school teacher is under fire after flashing topless photos to stunned students during a classroom presentation, according to the principal. The unidentified teacher at Glacier ...
CARSON CITY, Nev., April 14, 2026 (GLOBE NEWSWIRE)-- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
Leukogene Therapeutics, Inc., an early‑stage oncology company developing MHC class II-engager immunotherapies for immunologically cold cancers, today announced two poster presentations at the American ...
Discover Gamma App! This AI tool creates presentations for YouTube videos and LinguaTrip classes based on provided outlines, helping you create more efficiently. Trump started the Iran war with 5 ...
Week-48 suppression was 91.8% with DOR/ISL vs 90.6% with BIC/FTC/TAF, with few discontinuations for inefficacy and similar overall tolerability. EMBRACE reported 12-month suppression rates of 94% (IV ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
The centerpiece of the Trump administration’s revamp of the U.S. Navy is the largest surface combatant America will build since World War II. The U.S. Navy will buy two new “battleships” as part of ...
Atacicept is an investigational recombinant fusion protein that contains the soluble transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) receptor that binds to the ...
Late Breaking Abstract titled EFFICACY OF OBEFAZIMOD IN ABTECT PHASE 3 INDUCTION TRIALS: RESULTS OF 8-WEEK THERAPY IN SUBSETS OF PATIENTS WITH AND WITHOUT PRIOR INADEQUATE RESPONSE TO ADVANCED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results